Update on the Supply of Epipen (Feb 2020)


13 FEBRUARY 2020

Availability of EpiPen® 0.3mg and 0.15mg AdrenalineAuto-Injectors

Mylan’s manufacturing partner Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen®, has experienced manufacturing challenges which has resulted in interruptions in the production of EpiPen 0.3mg and EpiPen Jr 0.15mg Adrenaline Auto-Injectors (AAIs). To help manage product availability on an ongoing basis until a steady supply resumes, Mylan assigned a prescription validation process for EpiPen 0.3mg, meaning patients can obtain up to a maximum of two EpiPen 0.3mg AAIs per prescription. There is no prescription validation process in place for EpiPen 0.15mg. Patients should follow the Instructions for Patients detailed below to fulfil their prescriptions and pharmacies should follow the Instructions for Pharmacists outlined below when placing orders.

Click here to view the full statement 

Latest News Headlines


Become a BSACI Member...

GPs, Nurses, Allergy Specialists, Dieticians, Generalists

Join BSACI to receive the regular BSACI Allergy Update, have online access to the monthly journal 'Clinical & Experimental Allergy’, download our popular guidelines and a discount to the BSACI Annual Meeting.

Join Now